speb/financial-data huggingface dataset:
Analyst earnings estimates for PHAR, period 0y (report date 2026-05-30):
Average estimate: 0.20 USD
Low estimate: 0.05
High estimate: 0.48
Number of analysts: 3
Year-ago value: 0.04
Growth: 4.01
Analyst revenue estimates for PHAR, period 0y (report date 2026-05-30):
Average estimate: 403525000.00 USD
Low estimate: 390100000.00
High estimate: 412900000.00
Number of analysts: 4
Year-ago value: 376134000.00
Growth: 0.07
Analyst earnings estimates for PHAR, period +1q (report date 2026-06-07):
Average estimate: 0.07 USD
Low estimate: 0.02
High estimate: 0.17
Number of analysts: 3
Year-ago value: 0.01
Growth: 6.20
Analyst revenue estimates for PHAR, period +1q (report date 2026-06-07):
Average estimate: 109716670.00 USD
Low estimate: 105000000.00
High estimate: 113450000.00
Number of analysts: 3
Year-ago value: 97287000.00
Growth: 0.13
Analyst earnings estimates for PHAR, period +1y (report date 2026-06-07):
Average estimate: 0.29 USD
Low estimate: 0.05
High estimate: 0.74
Number of analysts: 3
Year-ago value: 0.20
Growth: 0.45
Analyst revenue estimates for PHAR, period +1y (report date 2026-06-07):
Average estimate: 447797800.00 USD
Low estimate: 415600000.00
High estimate: 531189000.00
Number of analysts: 5
Year-ago value: 403525000.00
Growth: 0.11
Analyst earnings estimates for PHAR, period 0q (report date 2026-06-07):
Average estimate: 0.06 USD
Low estimate: 0.01
High estimate: 0.13
Number of analysts: 3
Year-ago value: 0.01
Growth: 8.39
Analyst revenue estimates for PHAR, period 0q (report date 2026-06-07):
Average estimate: 101283330.00 USD
Low estimate: 90500000.00
High estimate: 110750000.00
Number of analysts: 3
Year-ago value: 93221000.00
Growth: 0.09
Analyst earnings estimates for PHAR, period 0y (report date 2026-06-07):
Average estimate: 0.20 USD
Low estimate: 0.05
High estimate: 0.48
Number of analysts: 3
Year-ago value: 0.04
Growth: 4.01
Analyst revenue estimates for PHAR, period 0y (report date 2026-06-07):
Average estimate: 403525000.00 USD
Low estimate: 390100000.00
High estimate: 412900000.00
Number of analysts: 4
Year-ago value: 376134000.00
Growth: 0.07
Analyst earnings estimates for PHAR, period +1q (report date 2026-06-23):
Average estimate: 0.07 USD
Low estimate: 0.02
High estimate: 0.17
Number of analysts: 3
Year-ago value: 0.01
Growth: 6.20
Analyst revenue estimates for PHAR, period +1q (report date 2026-06-23):
Average estimate: 109716670.00 USD
Low estimate: 105000000.00
High estimate: 113450000.00
Number of analysts: 3
Year-ago value: 97287000.00
Growth: 0.13
Analyst earnings estimates for PHAR, period +1y (report date 2026-06-23):
Average estimate: 0.29 USD
Low estimate: 0.05
High estimate: 0.74
Number of analysts: 3
Year-ago value: 0.20
Growth: 0.45
Analyst revenue estimates for PHAR, period +1y (report date 2026-06-23):
Average estimate: 447797800.00 USD
Low estimate: 415600000.00
High estimate: 531189000.00
Number of analysts: 5
Year-ago value: 403525000.00
Growth: 0.11
Analyst earnings estimates for PHAR, period 0q (report date 2026-06-23):
Average estimate: 0.06 USD
Low estimate: 0.01
High estimate: 0.13
Number of analysts: 3
Year-ago value: 0.01
Growth: 8.39
Analyst revenue estimates for PHAR, period 0q (report date 2026-06-23):
Average estimate: 101283330.00 USD
Low estimate: 90500000.00
High estimate: 110750000.00
Number of analysts: 3
Year-ago value: 93221000.00
Growth: 0.09
Analyst earnings estimates for PHAR, period 0y (report date 2026-06-23):
Average estimate: 0.20 USD
Low estimate: 0.05
High estimate: 0.48
Number of analysts: 3
Year-ago value: 0.04
Growth: 4.01
Analyst revenue estimates for PHAR, period 0y (report date 2026-06-23):
Average estimate: 403525000.00 USD
Low estimate: 390100000.00
High estimate: 412900000.00
Number of analysts: 4
Year-ago value: 376134000.00
Growth: 0.07
Analyst earnings estimates for PHAR, period +1q (report date 2026-07-11):
Average estimate: 0.08 USD
Low estimate: 0.02
High estimate: 0.20
Number of analysts: 3
Year-ago value: 0.01
Growth: 7.20
Analyst revenue estimates for PHAR, period +1q (report date 2026-07-11):
Average estimate: 109716670.00 USD
Low estimate: 105000000.00
High estimate: 113450000.00
Number of analysts: 3
Year-ago value: 97287000.00
Growth: 0.13
Analyst earnings estimates for PHAR, period +1y (report date 2026-07-11):
Average estimate: 0.07 USD
Low estimate: 0.05
High estimate: 0.08
Number of analysts: 2
Year-ago value: 0.23
Growth: -0.72
Analyst revenue estimates for PHAR, period +1y (report date 2026-07-11):
Average estimate: 447797800.00 USD
Low estimate: 415600000.00
High estimate: 531189000.00
Number of analysts: 5
Year-ago value: 403525000.00
Growth: 0.11
Analyst earnings estimates for PHAR, period 0q (report date 2026-07-11):
Average estimate: 0.06 USD
Low estimate: 0.01
High estimate: 0.15
Number of analysts: 3
Year-ago value: 0.01
Growth: 9.50
Analyst revenue estimates for PHAR, period 0q (report date 2026-07-11):
Average estimate: 101283330.00 USD
Low estimate: 90500000.00
High estimate: 110750000.00
Number of analysts: 3
Year-ago value: 93221000.00
Growth: 0.09
Analyst earnings estimates for PHAR, period 0y (report date 2026-07-11):
Average estimate: 0.23 USD
Low estimate: 0.05
High estimate: 0.57
Number of analysts: 3
Year-ago value: 0.04
Growth: 4.76
Analyst revenue estimates for PHAR, period 0y (report date 2026-07-11):
Average estimate: 403525000.00 USD
Low estimate: 390100000.00
High estimate: 412900000.00
Number of analysts: 4
Year-ago value: 376134000.00
Growth: 0.07
Analyst earnings estimates for PHAR, period +1q (report date 2026-07-19):
Average estimate: 0.08 USD
Low estimate: 0.02
High estimate: 0.20
Number of analysts: 3
Year-ago value: 0.01
Growth: 7.20
Analyst revenue estimates for PHAR, period +1q (report date 2026-07-19):
Average estimate: 109716670.00 USD
Low estimate: 105000000.00
High estimate: 113450000.00
Number of analysts: 3
Year-ago value: 97287000.00
Growth: 0.13
Analyst earnings estimates for PHAR, period +1y (report date 2026-07-19):
Average estimate: 0.07 USD
Low estimate: 0.05
High estimate: 0.08
Number of analysts: 2
Year-ago value: 0.23
Growth: -0.72
Analyst revenue estimates for PHAR, period +1y (report date 2026-07-19):
Average estimate: 447797800.00 USD
Low estimate: 415600000.00
High estimate: 531189000.00
Number of analysts: 5
Year-ago value: 403525000.00
Growth: 0.11
Analyst earnings estimates for PHAR, period 0q (report date 2026-07-19):
Average estimate: 0.06 USD
Low estimate: 0.01
High estimate: 0.15
Number of analysts: 3
Year-ago value: 0.01
Growth: 9.50
Analyst revenue estimates for PHAR, period 0q (report date 2026-07-19):
Average estimate: 101283330.00 USD
Low estimate: 90500000.00
High estimate: 110750000.00
Number of analysts: 3
Year-ago value: 93221000.00
Growth: 0.09
Analyst earnings estimates for PHAR, period 0y (report date 2026-07-19):
Average estimate: 0.23 USD
Low estimate: 0.05
High estimate: 0.57
Number of analysts: 3
Year-ago value: 0.04
Growth: 4.76
Analyst revenue estimates for PHAR, period 0y (report date 2026-07-19):
Average estimate: 403525000.00 USD
Low estimate: 390100000.00
High estimate: 412900000.00
Number of analysts: 4
Year-ago value: 376134000.00
Growth: 0.07
Analyst earnings estimates for PHAR, period +1q (report date 2026-07-25):
Average estimate: 0.08 USD
Low estimate: 0.02
High estimate: 0.20
Number of analysts: 3
Year-ago value: 0.01
Growth: 7.20
Analyst revenue estimates for PHAR, period +1q (report date 2026-07-25):
Average estimate: 110292750.00 USD
Low estimate: 105000000.00
High estimate: 113450000.00
Number of analysts: 4
Year-ago value: 97287000.00
Growth: 0.13
Analyst earnings estimates for PHAR, period +1y (report date 2026-07-25):
Average estimate: 0.07 USD
Low estimate: 0.05
High estimate: 0.08
Number of analysts: 2
Year-ago value: 0.23
Growth: -0.72
Analyst revenue estimates for PHAR, period +1y (report date 2026-07-25):
Average estimate: 438939600.00 USD
Low estimate: 415600000.00
High estimate: 486898000.00
Number of analysts: 5
Year-ago value: 404012000.00
Growth: 0.09
Analyst earnings estimates for PHAR, period 0q (report date 2026-07-25):
Average estimate: 0.06 USD
Low estimate: 0.01
High estimate: 0.15
Number of analysts: 3
Year-ago value: 0.01
Growth: 9.50
Analyst revenue estimates for PHAR, period 0q (report date 2026-07-25):
Average estimate: 99515500.00 USD
Low estimate: 90500000.00
High estimate: 110750000.00
Number of analysts: 4
Year-ago value: 93221000.00
Growth: 0.07
Analyst earnings estimates for PHAR, period 0y (report date 2026-07-25):
Average estimate: 0.23 USD
Low estimate: 0.05
High estimate: 0.57
Number of analysts: 3
Year-ago value: 0.04
Growth: 4.76
Analyst revenue estimates for PHAR, period 0y (report date 2026-07-25):
Average estimate: 404012000.00 USD
Low estimate: 390100000.00
High estimate: 412900000.00
Number of analysts: 5
Year-ago value: 376134000.00
Growth: 0.07
Analyst revenue estimates for PHAR.L, period +1q (report date 2026-06-01):
Average estimate: 0.00 USD
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHAR.L, period +1y (report date 2026-06-01):
Average estimate: 0.05 USD
Low estimate: -0.03
High estimate: 0.12
Number of analysts: 3
Year-ago value: 0.05
Growth: 0.07
Analyst revenue estimates for PHAR.L, period +1y (report date 2026-06-01):
Average estimate: 134875000.00 USD
Low estimate: 111900000.00
High estimate: 166800000.00
Number of analysts: 4
Year-ago value: 139425000.00
Growth: -0.03
Analyst revenue estimates for PHAR.L, period 0q (report date 2026-06-01):
Average estimate: 0.00 USD
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHAR.L, period 0y (report date 2026-06-01):
Average estimate: 0.05 USD
Low estimate: -0.02
High estimate: 0.09
Number of analysts: 3
Year-ago value: -0.02
Growth: 3.77
Analyst revenue estimates for PHAR.L, period 0y (report date 2026-06-01):
Average estimate: 139425000.00 USD
Low estimate: 114000000.00
High estimate: 150600000.00
Number of analysts: 4
Year-ago value: 114600000.00
Growth: 0.22
Analyst revenue estimates for PHAR.L, period +1q (report date 2026-06-20):
Average estimate: 0.00 USD
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHAR.L, period +1y (report date 2026-06-20):
Average estimate: 0.01 USD
Low estimate: -0.03
High estimate: 0.07
Number of analysts: 4
Year-ago value: 0.03
Growth: -0.61
Analyst revenue estimates for PHAR.L, period +1y (report date 2026-06-20):
Average estimate: 148450000.00 USD
Low estimate: 119800000.00
High estimate: 170000000.00
Number of analysts: 4
Year-ago value: 152600000.00
Growth: -0.03
Analyst revenue estimates for PHAR.L, period 0q (report date 2026-06-20):
Average estimate: 0.00 USD
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHAR.L, period 0y (report date 2026-06-20):
Average estimate: 0.03 USD
Low estimate: -0.02
High estimate: 0.08
Number of analysts: 4
Year-ago value: -0.02
Growth: 2.87
Analyst revenue estimates for PHAR.L, period 0y (report date 2026-06-20):
Average estimate: 152600000.00 USD
Low estimate: 143900000.00
High estimate: 164600000.00
Number of analysts: 4
Year-ago value: 114600000.00
Growth: 0.33
Analyst revenue estimates for PHAR.L, period +1q (report date 2026-06-23):
Average estimate: 0.00 USD
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHAR.L, period +1y (report date 2026-06-23):
Average estimate: 0.01 USD
Low estimate: -0.03
High estimate: 0.07
Number of analysts: 4
Year-ago value: 0.03
Growth: -0.61
Analyst revenue estimates for PHAR.L, period +1y (report date 2026-06-23):
Average estimate: 148450000.00 USD
Low estimate: 119800000.00
High estimate: 170000000.00
Number of analysts: 4
Year-ago value: 152600000.00
Growth: -0.03
Analyst revenue estimates for PHAR.L, period 0q (report date 2026-06-23):
Average estimate: 0.00 USD
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHAR.L, period 0y (report date 2026-06-23):
Average estimate: 0.03 USD
Low estimate: -0.02
High estimate: 0.08
Number of analysts: 4
Year-ago value: -0.02
Growth: 2.87
Analyst revenue estimates for PHAR.L, period 0y (report date 2026-06-23):
Average estimate: 152600000.00 USD
Low estimate: 143900000.00
High estimate: 164600000.00
Number of analysts: 4
Year-ago value: 114600000.00
Growth: 0.33
Analyst revenue estimates for PHAR.L, period +1q (report date 2026-07-11):
Average estimate: 0.00 USD
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHAR.L, period +1y (report date 2026-07-11):
Average estimate: 0.01 USD
Low estimate: -0.03
High estimate: 0.07
Number of analysts: 4
Year-ago value: 0.03
Growth: -0.61
Analyst revenue estimates for PHAR.L, period +1y (report date 2026-07-11):
Average estimate: 141266670.00 USD
Low estimate: 119800000.00
High estimate: 166800000.00
Number of analysts: 3
Year-ago value: 154800000.00
Growth: -0.09
Analyst revenue estimates for PHAR.L, period 0q (report date 2026-07-11):
Average estimate: 0.00 USD
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHAR.L, period 0y (report date 2026-07-11):
Average estimate: 0.03 USD
Low estimate: -0.02
High estimate: 0.08
Number of analysts: 4
Year-ago value: -0.02
Growth: 2.87
Analyst revenue estimates for PHAR.L, period 0y (report date 2026-07-11):
Average estimate: 154800000.00 USD
Low estimate: 143900000.00
High estimate: 164600000.00
Number of analysts: 3
Year-ago value: 114600000.00
Growth: 0.35
Analyst revenue estimates for PHAR.L, period +1q (report date 2026-07-19):
Average estimate: 0.00 USD
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHAR.L, period +1y (report date 2026-07-19):
Average estimate: 0.01 USD
Low estimate: -0.03
High estimate: 0.07
Number of analysts: 4
Year-ago value: 0.03
Growth: -0.61
Analyst revenue estimates for PHAR.L, period +1y (report date 2026-07-19):
Average estimate: 141266670.00 USD
Low estimate: 119800000.00
High estimate: 166800000.00
Number of analysts: 3
Year-ago value: 154800000.00
Growth: -0.09
Analyst revenue estimates for PHAR.L, period 0q (report date 2026-07-19):
Average estimate: 0.00 USD
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHAR.L, period 0y (report date 2026-07-19):
Average estimate: 0.03 USD
Low estimate: -0.02
High estimate: 0.08
Number of analysts: 4
Year-ago value: -0.02
Growth: 2.87
Analyst revenue estimates for PHAR.L, period 0y (report date 2026-07-19):
Average estimate: 154800000.00 USD
Low estimate: 143900000.00
High estimate: 164600000.00
Number of analysts: 3
Year-ago value: 114600000.00
Growth: 0.35
Analyst revenue estimates for PHAR.L, period +1q (report date 2026-07-25):
Average estimate: 0.00 USD
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHAR.L, period +1y (report date 2026-07-25):
Average estimate: 0.01 USD
Low estimate: -0.03
High estimate: 0.07
Number of analysts: 4
Year-ago value: 0.03
Growth: -0.61
Analyst revenue estimates for PHAR.L, period +1y (report date 2026-07-25):
Average estimate: 141266670.00 USD
Low estimate: 119800000.00
High estimate: 166800000.00
Number of analysts: 3
Year-ago value: 154800000.00
Growth: -0.09
Analyst revenue estimates for PHAR.L, period 0q (report date 2026-07-25):
Average estimate: 0.00 USD
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHAR.L, period 0y (report date 2026-07-25):
Average estimate: 0.03 USD
Low estimate: -0.02
High estimate: 0.08
Number of analysts: 4
Year-ago value: -0.02
Growth: 2.87
Analyst revenue estimates for PHAR.L, period 0y (report date 2026-07-25):
Average estimate: 154800000.00 USD
Low estimate: 143900000.00
High estimate: 164600000.00
Number of analysts: 3
Year-ago value: 114600000.00
Growth: 0.35
Analyst revenue estimates for PHARM.AS, period +1q (report date 2026-06-07):
Average estimate: 109716670.00 USD
Low estimate: 105000000.00
High estimate: 113450000.00
Number of analysts: 3
Year-ago value: 97287000.00
Growth: 0.13
Analyst earnings estimates for PHARM.AS, period +1y (report date 2026-06-07):
Average estimate: 0.04 USD
Low estimate: -0.01
High estimate: 0.08
Number of analysts: 2
Year-ago value: 0.03
Growth: 0.18
Analyst revenue estimates for PHARM.AS, period +1y (report date 2026-06-07):
Average estimate: 447797800.00 USD
Low estimate: 415600000.00
High estimate: 531189000.00
Number of analysts: 5
Year-ago value: 403525000.00
Growth: 0.11
Analyst revenue estimates for PHARM.AS, period 0q (report date 2026-06-07):
Average estimate: 101283330.00 USD
Low estimate: 90500000.00
High estimate: 110750000.00
Number of analysts: 3
Year-ago value: 93221000.00
Growth: 0.09
Analyst earnings estimates for PHARM.AS, period 0y (report date 2026-06-07):
Average estimate: 0.03 USD
Low estimate: 0.01
High estimate: 0.05
Number of analysts: 2
Year-ago value: 0.00
Growth: 6.69
Analyst revenue estimates for PHARM.AS, period 0y (report date 2026-06-07):
Average estimate: 403525000.00 USD
Low estimate: 390100000.00
High estimate: 412900000.00
Number of analysts: 4
Year-ago value: 376134000.00
Growth: 0.07
Analyst revenue estimates for PHARM.AS, period +1q (report date 2026-06-20):
Average estimate: 109716670.00 USD
Low estimate: 105000000.00
High estimate: 113450000.00
Number of analysts: 3
Year-ago value: 97287000.00
Growth: 0.13
Analyst earnings estimates for PHARM.AS, period +1y (report date 2026-06-20):
Average estimate: 0.04 USD
Low estimate: -0.01
High estimate: 0.08
Number of analysts: 2
Year-ago value: 0.03
Growth: 0.18
Analyst revenue estimates for PHARM.AS, period +1y (report date 2026-06-20):
Average estimate: 447797800.00 USD
Low estimate: 415600000.00
High estimate: 531189000.00
Number of analysts: 5
Year-ago value: 403525000.00
Growth: 0.11
Analyst revenue estimates for PHARM.AS, period 0q (report date 2026-06-20):
Average estimate: 101283330.00 USD
Low estimate: 90500000.00
High estimate: 110750000.00
Number of analysts: 3
Year-ago value: 93221000.00
Growth: 0.09
Analyst earnings estimates for PHARM.AS, period 0y (report date 2026-06-20):
Average estimate: 0.03 USD
Low estimate: 0.01
High estimate: 0.05
Number of analysts: 2
Year-ago value: 0.00
Growth: 6.69
Analyst revenue estimates for PHARM.AS, period 0y (report date 2026-06-20):
Average estimate: 403525000.00 USD
Low estimate: 390100000.00
High estimate: 412900000.00
Number of analysts: 4
Year-ago value: 376134000.00
Growth: 0.07
Analyst revenue estimates for PHARM.AS, period +1q (report date 2026-06-23):
Average estimate: 109716670.00 USD
Low estimate: 105000000.00
High estimate: 113450000.00
Number of analysts: 3
Year-ago value: 97287000.00
Growth: 0.13
Analyst earnings estimates for PHARM.AS, period +1y (report date 2026-06-23):
Average estimate: 0.04 USD
Low estimate: -0.01
High estimate: 0.08
Number of analysts: 2
Year-ago value: 0.03
Growth: 0.18
Analyst revenue estimates for PHARM.AS, period +1y (report date 2026-06-23):
Average estimate: 447797800.00 USD
Low estimate: 415600000.00
High estimate: 531189000.00
Number of analysts: 5
Year-ago value: 403525000.00
Growth: 0.11
Analyst revenue estimates for PHARM.AS, period 0q (report date 2026-06-23):
Average estimate: 101283330.00 USD
Low estimate: 90500000.00
High estimate: 110750000.00
Number of analysts: 3
Year-ago value: 93221000.00
Growth: 0.09
Analyst earnings estimates for PHARM.AS, period 0y (report date 2026-06-23):
Average estimate: 0.03 USD
Low estimate: 0.01
High estimate: 0.05
Number of analysts: 2
Year-ago value: 0.00
Growth: 6.69
Analyst revenue estimates for PHARM.AS, period 0y (report date 2026-06-23):
Average estimate: 403525000.00 USD
Low estimate: 390100000.00
High estimate: 412900000.00
Number of analysts: 4
Year-ago value: 376134000.00
Growth: 0.07
Analyst revenue estimates for PHARM.AS, period +1q (report date 2026-07-11):
Average estimate: 109716670.00 USD
Low estimate: 105000000.00
High estimate: 113450000.00
Number of analysts: 3
Year-ago value: 97287000.00
Growth: 0.13
Analyst earnings estimates for PHARM.AS, period +1y (report date 2026-07-11):
Average estimate: 0.04 USD
Low estimate: -0.01
High estimate: 0.08
Number of analysts: 2
Year-ago value: 0.03
Growth: 0.18
Analyst revenue estimates for PHARM.AS, period +1y (report date 2026-07-11):
Average estimate: 447797800.00 USD
Low estimate: 415600000.00
High estimate: 531189000.00
Number of analysts: 5
Year-ago value: 403525000.00
Growth: 0.11
Analyst revenue estimates for PHARM.AS, period 0q (report date 2026-07-11):
Average estimate: 101283330.00 USD
Low estimate: 90500000.00
High estimate: 110750000.00
Number of analysts: 3
Year-ago value: 93221000.00
Growth: 0.09
Analyst earnings estimates for PHARM.AS, period 0y (report date 2026-07-11):
Average estimate: 0.03 USD
Low estimate: 0.01
High estimate: 0.05
Number of analysts: 2
Year-ago value: 0.00
Growth: 6.69
Analyst revenue estimates for PHARM.AS, period 0y (report date 2026-07-11):
Average estimate: 403525000.00 USD
Low estimate: 390100000.00
High estimate: 412900000.00
Number of analysts: 4
Year-ago value: 376134000.00
Growth: 0.07
Analyst earnings estimates for PHAT, period +1q (report date 2026-05-30):
Average estimate: 0.05 USD
Low estimate: 0.02
High estimate: 0.11
Number of analysts: 3
Year-ago value: -0.15
Growth: 1.33
Analyst revenue estimates for PHAT, period +1q (report date 2026-05-30):
Average estimate: 93111880.00 USD
Low estimate: 90000000.00
High estimate: 96619000.00
Number of analysts: 8
Year-ago value: 49504000.00
Growth: 0.88
Analyst earnings estimates for PHAT, period +1y (report date 2026-05-30):
Average estimate: 1.44 USD
Low estimate: 1.17
High estimate: 1.92
Number of analysts: 3
Year-ago value: -0.04
Growth: 33.70
Analyst revenue estimates for PHAT, period +1y (report date 2026-05-30):
Average estimate: 539954000.00 USD
Low estimate: 498809000.00
High estimate: 653200000.00
Number of analysts: 9
Year-ago value: 334094000.00
Growth: 0.62
Analyst earnings estimates for PHAT, period 0q (report date 2026-05-30):
Average estimate: -0.10 USD
Low estimate: -0.14
High estimate: -0.06
Number of analysts: 3
Year-ago value: -0.79
Growth: 0.88
Analyst revenue estimates for PHAT, period 0q (report date 2026-05-30):
Average estimate: 73978000.00 USD
Low estimate: 72300000.00
High estimate: 75946000.00
Number of analysts: 8
Year-ago value: 39503000.00
Growth: 0.87
Analyst earnings estimates for PHAT, period 0y (report date 2026-05-30):
Average estimate: -0.04 USD
Low estimate: -0.13
High estimate: 0.09
Number of analysts: 3
Year-ago value: -2.06
Growth: 0.98
Analyst revenue estimates for PHAT, period 0y (report date 2026-05-30):
Average estimate: 334094000.00 USD
Low estimate: 330300000.00
High estimate: 338306000.00
Number of analysts: 9
Year-ago value: 175110000.00
Growth: 0.91
Analyst earnings estimates for PHAT, period +1q (report date 2026-06-07):
Average estimate: 0.05 USD
Low estimate: 0.02
High estimate: 0.11
Number of analysts: 3
Year-ago value: -0.15
Growth: 1.33
Analyst revenue estimates for PHAT, period +1q (report date 2026-06-07):
Average estimate: 93111880.00 USD
Low estimate: 90000000.00
High estimate: 96619000.00
Number of analysts: 8
Year-ago value: 49504000.00
Growth: 0.88
Analyst earnings estimates for PHAT, period +1y (report date 2026-06-07):
Average estimate: 1.44 USD
Low estimate: 1.17
High estimate: 1.92
Number of analysts: 3
Year-ago value: -0.04
Growth: 33.70
Analyst revenue estimates for PHAT, period +1y (report date 2026-06-07):
Average estimate: 539954000.00 USD
Low estimate: 498809000.00
High estimate: 653200000.00
Number of analysts: 9
Year-ago value: 334094000.00
Growth: 0.62
Analyst earnings estimates for PHAT, period 0q (report date 2026-06-07):
Average estimate: -0.10 USD
Low estimate: -0.14
High estimate: -0.06
Number of analysts: 3
Year-ago value: -0.79
Growth: 0.88
Analyst revenue estimates for PHAT, period 0q (report date 2026-06-07):
Average estimate: 73978000.00 USD
Low estimate: 72300000.00
High estimate: 75946000.00
Number of analysts: 8
Year-ago value: 39503000.00
Growth: 0.87
Analyst earnings estimates for PHAT, period 0y (report date 2026-06-07):
Average estimate: -0.04 USD
Low estimate: -0.13
High estimate: 0.09
Number of analysts: 3
Year-ago value: -2.06
Growth: 0.98
Analyst revenue estimates for PHAT, period 0y (report date 2026-06-07):
Average estimate: 334094000.00 USD
Low estimate: 330300000.00
High estimate: 338306000.00
Number of analysts: 9
Year-ago value: 175110000.00
Growth: 0.91
Analyst earnings estimates for PHAT, period +1q (report date 2026-06-20):
Average estimate: 0.05 USD
Low estimate: 0.02
High estimate: 0.11
Number of analysts: 3
Year-ago value: -0.15
Growth: 1.33
Analyst revenue estimates for PHAT, period +1q (report date 2026-06-20):
Average estimate: 93119250.00 USD
Low estimate: 90000000.00
High estimate: 96619000.00
Number of analysts: 8
Year-ago value: 49504000.00
Growth: 0.88
Analyst earnings estimates for PHAT, period +1y (report date 2026-06-20):
Average estimate: 1.44 USD
Low estimate: 1.17
High estimate: 1.92
Number of analysts: 3
Year-ago value: -0.04
Growth: 33.70
Analyst revenue estimates for PHAT, period +1y (report date 2026-06-20):
Average estimate: 539954000.00 USD
Low estimate: 498809000.00
High estimate: 653200000.00
Number of analysts: 9
Year-ago value: 334094000.00
Growth: 0.62
Analyst earnings estimates for PHAT, period 0q (report date 2026-06-20):
Average estimate: -0.10 USD
Low estimate: -0.14
High estimate: -0.06
Number of analysts: 3
Year-ago value: -0.79
Growth: 0.88
Analyst revenue estimates for PHAT, period 0q (report date 2026-06-20):
Average estimate: 73613620.00 USD
Low estimate: 72300000.00
High estimate: 75946000.00
Number of analysts: 8
Year-ago value: 39503000.00
Growth: 0.86
Analyst earnings estimates for PHAT, period 0y (report date 2026-06-20):
Average estimate: -0.04 USD
Low estimate: -0.13
High estimate: 0.09
Number of analysts: 3
Year-ago value: -2.06
Growth: 0.98
Analyst revenue estimates for PHAT, period 0y (report date 2026-06-20):
Average estimate: 334094000.00 USD
Low estimate: 330300000.00
High estimate: 338306000.00
Number of analysts: 9
Year-ago value: 175110000.00
Growth: 0.91
Analyst earnings estimates for PHAT, period +1q (report date 2026-06-23):
Average estimate: 0.05 USD
Low estimate: 0.02
High estimate: 0.11
Number of analysts: 3
Year-ago value: -0.15
Growth: 1.33
Analyst revenue estimates for PHAT, period +1q (report date 2026-06-23):
Average estimate: 93119250.00 USD
Low estimate: 90000000.00
High estimate: 96619000.00
Number of analysts: 8
Year-ago value: 49504000.00
Growth: 0.88
Analyst earnings estimates for PHAT, period +1y (report date 2026-06-23):
Average estimate: 1.44 USD
Low estimate: 1.17
High estimate: 1.92
Number of analysts: 3
Year-ago value: -0.04
Growth: 33.70
Analyst revenue estimates for PHAT, period +1y (report date 2026-06-23):
Average estimate: 539954000.00 USD
Low estimate: 498809000.00
High estimate: 653200000.00
Number of analysts: 9
Year-ago value: 334094000.00
Growth: 0.62
Analyst earnings estimates for PHAT, period 0q (report date 2026-06-23):
Average estimate: -0.10 USD
Low estimate: -0.14
High estimate: -0.06
Number of analysts: 3
Year-ago value: -0.79
Growth: 0.88
Analyst revenue estimates for PHAT, period 0q (report date 2026-06-23):
Average estimate: 73613620.00 USD
Low estimate: 72300000.00
High estimate: 75946000.00
Number of analysts: 8
Year-ago value: 39503000.00
Growth: 0.86
Analyst earnings estimates for PHAT, period 0y (report date 2026-06-23):
Average estimate: -0.04 USD
Low estimate: -0.13
High estimate: 0.09
Number of analysts: 3
Year-ago value: -2.06
Growth: 0.98
Analyst revenue estimates for PHAT, period 0y (report date 2026-06-23):
Average estimate: 334094000.00 USD
Low estimate: 330300000.00
High estimate: 338306000.00
Number of analysts: 9
Year-ago value: 175110000.00
Growth: 0.91
Analyst earnings estimates for PHAT, period +1q (report date 2026-07-11):
Average estimate: 0.05 USD
Low estimate: 0.02
High estimate: 0.11
Number of analysts: 3
Year-ago value: -0.15
Growth: 1.33
Analyst revenue estimates for PHAT, period +1q (report date 2026-07-11):
Average estimate: 93119250.00 USD
Low estimate: 90000000.00
High estimate: 96619000.00
Number of analysts: 8
Year-ago value: 49504000.00
Growth: 0.88
Analyst earnings estimates for PHAT, period +1y (report date 2026-07-11):
Average estimate: 1.44 USD
Low estimate: 1.17
High estimate: 1.92
Number of analysts: 3
Year-ago value: -0.04
Growth: 33.70
Analyst revenue estimates for PHAT, period +1y (report date 2026-07-11):
Average estimate: 539954000.00 USD
Low estimate: 498809000.00
High estimate: 653200000.00
Number of analysts: 9
Year-ago value: 334094000.00
Growth: 0.62
Analyst earnings estimates for PHAT, period 0q (report date 2026-07-11):
Average estimate: -0.10 USD
Low estimate: -0.14
High estimate: -0.06
Number of analysts: 3
Year-ago value: -0.79
Growth: 0.88
Analyst revenue estimates for PHAT, period 0q (report date 2026-07-11):
Average estimate: 73613620.00 USD
Low estimate: 72300000.00
High estimate: 75946000.00
Number of analysts: 8
Year-ago value: 39503000.00
Growth: 0.86
Analyst earnings estimates for PHAT, period 0y (report date 2026-07-11):
Average estimate: -0.04 USD
Low estimate: -0.13
High estimate: 0.09
Number of analysts: 3
Year-ago value: -2.06
Growth: 0.98
Analyst revenue estimates for PHAT, period 0y (report date 2026-07-11):
Average estimate: 334094000.00 USD
Low estimate: 330300000.00
High estimate: 338306000.00
Number of analysts: 9
Year-ago value: 175110000.00
Growth: 0.91
Analyst earnings estimates for PHAT, period +1q (report date 2026-07-19):
Average estimate: 0.05 USD
Low estimate: 0.02
High estimate: 0.11
Number of analysts: 3
Year-ago value: -0.15
Growth: 1.33
Analyst revenue estimates for PHAT, period +1q (report date 2026-07-19):
Average estimate: 93069250.00 USD
Low estimate: 90000000.00
High estimate: 96619000.00
Number of analysts: 8
Year-ago value: 49504000.00
Growth: 0.88
Analyst earnings estimates for PHAT, period +1y (report date 2026-07-19):
Average estimate: 1.44 USD
Low estimate: 1.17
High estimate: 1.92
Number of analysts: 3
Year-ago value: -0.04
Growth: 33.70
Analyst revenue estimates for PHAT, period +1y (report date 2026-07-19):
Average estimate: 539954000.00 USD
Low estimate: 498809000.00
High estimate: 653200000.00
Number of analysts: 9
Year-ago value: 334094000.00
Growth: 0.62
Analyst earnings estimates for PHAT, period 0q (report date 2026-07-19):
Average estimate: -0.10 USD
Low estimate: -0.14
High estimate: -0.06
Number of analysts: 3
Year-ago value: -0.79
Growth: 0.88
Analyst revenue estimates for PHAT, period 0q (report date 2026-07-19):
Average estimate: 73001120.00 USD
Low estimate: 69700000.00
High estimate: 75946000.00
Number of analysts: 8
Year-ago value: 39503000.00
Growth: 0.85
Analyst earnings estimates for PHAT, period 0y (report date 2026-07-19):
Average estimate: -0.04 USD
Low estimate: -0.13
High estimate: 0.09
Number of analysts: 3
Year-ago value: -2.06
Growth: 0.98
Analyst revenue estimates for PHAT, period 0y (report date 2026-07-19):
Average estimate: 334094000.00 USD
Low estimate: 330300000.00
High estimate: 338306000.00
Number of analysts: 9
Year-ago value: 175110000.00
Growth: 0.91
Analyst earnings estimates for PHAT, period +1q (report date 2026-07-25):
Average estimate: 0.05 USD
Low estimate: 0.02
High estimate: 0.11
Number of analysts: 4
Year-ago value: -0.15
Growth: 1.33
Analyst revenue estimates for PHAT, period +1q (report date 2026-07-25):
Average estimate: 92137220.00 USD
Low estimate: 90000000.00
High estimate: 95453000.00
Number of analysts: 9
Year-ago value: 49504000.00
Growth: 0.86
Analyst earnings estimates for PHAT, period +1y (report date 2026-07-25):
Average estimate: 1.43 USD
Low estimate: 1.17
High estimate: 1.92
Number of analysts: 4
Year-ago value: -0.04
Growth: 41.26
Analyst revenue estimates for PHAT, period +1y (report date 2026-07-25):
Average estimate: 539954000.00 USD
Low estimate: 498809000.00
High estimate: 653200000.00
Number of analysts: 9
Year-ago value: 333816220.00
Growth: 0.62
Analyst earnings estimates for PHAT, period 0q (report date 2026-07-25):
Average estimate: -0.10 USD
Low estimate: -0.14
High estimate: -0.06
Number of analysts: 4
Year-ago value: -0.79
Growth: 0.88
Analyst revenue estimates for PHAT, period 0q (report date 2026-07-25):
Average estimate: 72688780.00 USD
Low estimate: 69700000.00
High estimate: 74000000.00
Number of analysts: 9
Year-ago value: 39503000.00
Growth: 0.84
Analyst earnings estimates for PHAT, period 0y (report date 2026-07-25):
Average estimate: -0.04 USD
Low estimate: -0.13
High estimate: 0.09
Number of analysts: 4
Year-ago value: -2.06
Growth: 0.98
Analyst revenue estimates for PHAT, period 0y (report date 2026-07-25):
Average estimate: 333816220.00 USD
Low estimate: 332200000.00
High estimate: 338306000.00
Number of analysts: 9
Year-ago value: 175110000.00
Growth: 0.91
Analyst revenue estimates for PHD.V, period +1q (report date 2026-06-01):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period +1y (report date 2026-06-01):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period 0q (report date 2026-06-01):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period 0y (report date 2026-06-01):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period +1q (report date 2026-06-21):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period +1y (report date 2026-06-21):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period 0q (report date 2026-06-21):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period 0y (report date 2026-06-21):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period +1q (report date 2026-07-11):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period +1y (report date 2026-07-11):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period 0q (report date 2026-07-11):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period 0y (report date 2026-07-11):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period +1q (report date 2026-07-19):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period +1y (report date 2026-07-19):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period 0q (report date 2026-07-19):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period 0y (report date 2026-07-19):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period +1q (report date 2026-07-25):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period +1y (report date 2026-07-25):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period 0q (report date 2026-07-25):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHD.V, period 0y (report date 2026-07-25):
Average estimate: 0.00 
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst revenue estimates for PHE.L, period +1q (report date 2026-06-01):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHE.L, period +1y (report date 2026-06-01):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 1
Year-ago value: 0.00
Growth: 0.38
Analyst revenue estimates for PHE.L, period +1y (report date 2026-06-01):
Average estimate: 1656000.00 GBP
Low estimate: 1656000.00
High estimate: 1656000.00
Number of analysts: 1
Year-ago value: 849000.00
Growth: 0.95
Analyst revenue estimates for PHE.L, period 0q (report date 2026-06-01):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHE.L, period 0y (report date 2026-06-01):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 1
Analyst revenue estimates for PHE.L, period 0y (report date 2026-06-01):
Average estimate: 849000.00 GBP
Low estimate: 849000.00
High estimate: 849000.00
Number of analysts: 1
Analyst revenue estimates for PHE.L, period +1q (report date 2026-06-20):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHE.L, period +1y (report date 2026-06-20):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 1
Year-ago value: 0.00
Growth: 0.38
Analyst revenue estimates for PHE.L, period +1y (report date 2026-06-20):
Average estimate: 1656000.00 GBP
Low estimate: 1656000.00
High estimate: 1656000.00
Number of analysts: 1
Year-ago value: 849000.00
Growth: 0.95
Analyst revenue estimates for PHE.L, period 0q (report date 2026-06-20):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHE.L, period 0y (report date 2026-06-20):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 1
Analyst revenue estimates for PHE.L, period 0y (report date 2026-06-20):
Average estimate: 849000.00 GBP
Low estimate: 849000.00
High estimate: 849000.00
Number of analysts: 1
Analyst revenue estimates for PHE.L, period +1q (report date 2026-06-23):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHE.L, period +1y (report date 2026-06-23):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 1
Year-ago value: 0.00
Growth: 0.38
Analyst revenue estimates for PHE.L, period +1y (report date 2026-06-23):
Average estimate: 1656000.00 GBP
Low estimate: 1656000.00
High estimate: 1656000.00
Number of analysts: 1
Year-ago value: 849000.00
Growth: 0.95
Analyst revenue estimates for PHE.L, period 0q (report date 2026-06-23):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHE.L, period 0y (report date 2026-06-23):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 1
Analyst revenue estimates for PHE.L, period 0y (report date 2026-06-23):
Average estimate: 849000.00 GBP
Low estimate: 849000.00
High estimate: 849000.00
Number of analysts: 1
Analyst revenue estimates for PHE.L, period +1q (report date 2026-07-11):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHE.L, period +1y (report date 2026-07-11):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 1
Year-ago value: 0.00
Growth: 0.17
Analyst revenue estimates for PHE.L, period +1y (report date 2026-07-11):
Average estimate: 1557000.00 GBP
Low estimate: 1557000.00
High estimate: 1557000.00
Number of analysts: 1
Year-ago value: 1656000.00
Growth: -0.06
Analyst revenue estimates for PHE.L, period 0q (report date 2026-07-11):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHE.L, period 0y (report date 2026-07-11):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Year-ago value: 0.00
Growth: 0.14
Analyst revenue estimates for PHE.L, period 0y (report date 2026-07-11):
Average estimate: 849000.00 GBP
Low estimate: 849000.00
High estimate: 849000.00
Number of analysts: 1
Analyst revenue estimates for PHE.L, period +1q (report date 2026-07-19):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHE.L, period +1y (report date 2026-07-19):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 1
Year-ago value: 0.00
Growth: 0.17
Analyst revenue estimates for PHE.L, period +1y (report date 2026-07-19):
Average estimate: 1557000.00 GBP
Low estimate: 1557000.00
High estimate: 1557000.00
Number of analysts: 1
Year-ago value: 1656000.00
Growth: -0.06
Analyst revenue estimates for PHE.L, period 0q (report date 2026-07-19):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHE.L, period 0y (report date 2026-07-19):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 1
Year-ago value: 0.00
Growth: 0.14
Analyst revenue estimates for PHE.L, period 0y (report date 2026-07-19):
Average estimate: 1656000.00 GBP
Low estimate: 1656000.00
High estimate: 1656000.00
Number of analysts: 1
Year-ago value: 1232770.00
Growth: 0.34
Analyst revenue estimates for PHE.L, period +1q (report date 2026-07-25):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHE.L, period +1y (report date 2026-07-25):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 1
Year-ago value: 0.00
Growth: 0.17
Analyst revenue estimates for PHE.L, period +1y (report date 2026-07-25):
Average estimate: 1557000.00 GBP
Low estimate: 1557000.00
High estimate: 1557000.00
Number of analysts: 1
Year-ago value: 1656000.00
Growth: -0.06
Analyst revenue estimates for PHE.L, period 0q (report date 2026-07-25):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 0
Analyst earnings estimates for PHE.L, period 0y (report date 2026-07-25):
Average estimate: 0.00 GBP
Low estimate: 0.00
High estimate: 0.00
Number of analysts: 1
Year-ago value: 0.00
Growth: 0.14
Analyst revenue estimates for PHE.L, period 0y (report date 2026-07-25):
Average estimate: 1656000.00 GBP
Low estimate: 1656000.00
High estimate: 1656000.00
Number of analysts: 1
Year-ago value: 1232770.00
Growth: 0.34
Analyst earnings estimates for PHG, period +1q (report date 2026-05-30):
Average estimate: 0.41 USD
Low estimate: 0.41
High estimate: 0.41
Number of analysts: 1
Year-ago value: 0.41
Growth: 0.00
Analyst revenue estimates for PHG, period +1q (report date 2026-05-30):
Average estimate: 4433638560.00 EUR
Low estimate: 4409000000.00
High estimate: 4466113000.00
Number of analysts: 5
Year-ago value: 4302000000.00
Growth: 0.03
Analyst earnings estimates for PHG, period +1y (report date 2026-05-30):
Average estimate: 2.04 USD
Low estimate: 1.84
High estimate: 2.45
Number of analysts: 4
Year-ago value: 1.82
Growth: 0.12
Analyst revenue estimates for PHG, period +1y (report date 2026-05-30):
Average estimate: 18784225410.00 EUR
Low estimate: 18454100000.00
High estimate: 20226000000.00
Number of analysts: 18
Year-ago value: 17989470470.00
Growth: 0.04
Analyst earnings estimates for PHG, period 0q (report date 2026-05-30):
Average estimate: 0.40 USD
Low estimate: 0.40
High estimate: 0.40
Number of analysts: 1
Year-ago value: 0.42
Growth: -0.04
Analyst revenue estimates for PHG, period 0q (report date 2026-05-30):
Average estimate: 4309897780.00 EUR
Low estimate: 4268100000.00
High estimate: 4345416900.00
Number of analysts: 5
Year-ago value: 4338000000.00
Growth: -0.01
Analyst earnings estimates for PHG, period 0y (report date 2026-05-30):
Average estimate: 1.82 USD
Low estimate: 1.61
High estimate: 2.15
Number of analysts: 4
Year-ago value: 1.86
Growth: -0.02
Analyst revenue estimates for PHG, period 0y (report date 2026-05-30):
Average estimate: 17989470470.00 EUR
Low estimate: 17707700000.00
High estimate: 19290000000.00
Number of analysts: 18
Year-ago value: 17834000000.00
Growth: 0.01
Analyst earnings estimates for PHG, period +1q (report date 2026-06-07):
Average estimate: 0.41 USD
Low estimate: 0.41
High estimate: 0.41
Number of analysts: 1
Year-ago value: 0.41
Growth: 0.00
Analyst revenue estimates for PHG, period +1q (report date 2026-06-07):
Average estimate: 4433638560.00 EUR
Low estimate: 4409000000.00
High estimate: 4466113000.00
Number of analysts: 5
Year-ago value: 4302000000.00
Growth: 0.03
Analyst earnings estimates for PHG, period +1y (report date 2026-06-07):
Average estimate: 2.04 USD
Low estimate: 1.84
High estimate: 2.43
Number of analysts: 4
Year-ago value: 1.82
Growth: 0.12
Analyst revenue estimates for PHG, period +1y (report date 2026-06-07):
Average estimate: 18782817080.00 EUR
Low estimate: 18454100000.00
High estimate: 20226000000.00
Number of analysts: 18
Year-ago value: 17989149910.00
Growth: 0.04
Analyst earnings estimates for PHG, period 0q (report date 2026-06-07):
Average estimate: 0.40 USD
Low estimate: 0.40
High estimate: 0.40
Number of analysts: 1
Year-ago value: 0.42
Growth: -0.04
Analyst revenue estimates for PHG, period 0q (report date 2026-06-07):
Average estimate: 4309897780.00 EUR
Low estimate: 4268100000.00
High estimate: 4345416900.00
Number of analysts: 5
Year-ago value: 4338000000.00
Growth: -0.01
Analyst earnings estimates for PHG, period 0y (report date 2026-06-07):
Average estimate: 1.82 USD
Low estimate: 1.61
High estimate: 2.14
Number of analysts: 4
Year-ago value: 1.86
Growth: -0.02
Analyst revenue estimates for PHG, period 0y (report date 2026-06-07):
Average estimate: 17989149910.00 EUR
Low estimate: 17707700000.00
High estimate: 19290000000.00
Number of analysts: 18
Year-ago value: 17834000000.00
Growth: 0.01
Analyst earnings estimates for PHG, period +1q (report date 2026-06-20):
Average estimate: 0.41 USD
Low estimate: 0.41
High estimate: 0.41
Number of analysts: 1
Year-ago value: 0.41
Growth: 0.00
Analyst revenue estimates for PHG, period +1q (report date 2026-06-20):
Average estimate: 4433638560.00 EUR
Low estimate: 4409000000.00
High estimate: 4466113000.00
Number of analysts: 5
Year-ago value: 4302000000.00
Growth: 0.03
Analyst earnings estimates for PHG, period +1y (report date 2026-06-20):
Average estimate: 2.04 USD
Low estimate: 1.84
High estimate: 2.43
Number of analysts: 4
Year-ago value: 1.82
Growth: 0.12
Analyst revenue estimates for PHG, period +1y (report date 2026-06-20):
Average estimate: 18782817080.00 EUR
Low estimate: 18454100000.00
High estimate: 20226000000.00
Number of analysts: 18
Year-ago value: 17989149910.00
Growth: 0.04
Analyst earnings estimates for PHG, period 0q (report date 2026-06-20):
Average estimate: 0.40 USD
Low estimate: 0.40
High estimate: 0.40
Number of analysts: 1
Year-ago value: 0.42
Growth: -0.04
Analyst revenue estimates for PHG, period 0q (report date 2026-06-20):
Average estimate: 4309897780.00 EUR
Low estimate: 4268100000.00
High estimate: 4345416900.00
Number of analysts: 5
Year-ago value: 4338000000.00
Growth: -0.01
Analyst earnings estimates for PHG, period 0y (report date 2026-06-20):
Average estimate: 1.82 USD
Low estimate: 1.61
High estimate: 2.14
Number of analysts: 4
Year-ago value: 1.86
Growth: -0.02
Analyst revenue estimates for PHG, period 0y (report date 2026-06-20):
Average estimate: 17989149910.00 EUR
Low estimate: 17707700000.00
High estimate: 19290000000.00
Number of analysts: 18
Year-ago value: 17834000000.00
Growth: 0.01
Analyst earnings estimates for PHG, period +1q (report date 2026-06-23):
Average estimate: 0.41 USD
Low estimate: 0.41
High estimate: 0.41
Number of analysts: 1
Year-ago value: 0.41
Growth: 0.00
Analyst revenue estimates for PHG, period +1q (report date 2026-06-23):
Average estimate: 4433638560.00 EUR
Low estimate: 4409000000.00
High estimate: 4466113000.00
Number of analysts: 5
Year-ago value: 4302000000.00
Growth: 0.03
Analyst earnings estimates for PHG, period +1y (report date 2026-06-23):
Average estimate: 2.04 USD
Low estimate: 1.84
High estimate: 2.43
Number of analysts: 4
Year-ago value: 1.82
Growth: 0.12
Analyst revenue estimates for PHG, period +1y (report date 2026-06-23):
Average estimate: 18772539290.00 EUR
Low estimate: 18454100000.00
High estimate: 20226000000.00
Number of analysts: 18
Year-ago value: 17979528750.00
Growth: 0.04
Analyst earnings estimates for PHG, period 0q (report date 2026-06-23):
Average estimate: 0.40 USD
Low estimate: 0.40
High estimate: 0.40
Number of analysts: 1
Year-ago value: 0.42
Growth: -0.04